LandOfFree - US Patents - Listing for Drug, bio-affecting and body treating compositions,Designated organic active ingredient containing,Peptide containing doai

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai

Rectal motilin preparation

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai

Redox-stable, non-phosphorylated cyclic peptide inhibitors...

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai

Reduced FK228 and use thereof

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai

Reduced peptides which inhibit gastric secretion, process for th

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai

Reduced side-effect hemoglobin compositions

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai

Reduced side-effect hemoglobin compositions

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai

Reduced volume formulation of glatiramer acetate and methods...

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai

Reducing agent for reductive alkylation of glycopeptide antibiot

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai

Reducing axon degeneration with proteasome inhibitors

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai

Reducing axon degeneration with proteasome inhibitors

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai

Reducing post-prandial fluctuations in plasma concentrations of

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai

Reducing postoperative astigmatism

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai

Reduction of anthracycline induced cardiotoxicity

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai

Reduction of breast density with 4-hydroxy tamoxifen

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai

Reduction of impairment of respiratory tract mucosal immunity

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai

Reduction of impairment of respiratory tract mucosal immunity

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai

Reduction of mammalian neoplasms with phospholipase A2 activatin

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai

Reduction of oxyradical damage in biomedical applications

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai

Reduction of the electrocardiographic QT interval